Suppr超能文献

维生素D对2型糖尿病患者蛋白尿的影响。

Effect of vitamin D on proteinuria in type 2 diabetic patients.

作者信息

Momeni Ali, Mirhosseini Mahmood, Kabiri Mohsen, Kheiri Soleiman

机构信息

Department of Internal Medicine, Shahrekord University of Medical Sciences, Shahrekord, Iran.

Social Health Determinants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.

出版信息

J Nephropathol. 2017 Jan;6(1):10-14. doi: 10.15171/jnp.2017.03. Epub 2016 Aug 14.

Abstract

BACKGROUND

Vitamin D (Vit D) deficiency is a common disorder in diabetic patients and may be a risk factor for ischemic heart disease and exacerbation of diabetic nephropathy(DN).

OBJECTIVES

The aim of this study was to evaluate the effect of Vit D3 therapy on protein uriain type 2 diabetic patients with deficient or insufficient serum Vit D.

PATIENTS AND METHODS

In a double blind clinical trial, 60 type 2 diabetic patients with proteinuria greater than 150 mg/day who had Vit D deficiency or insufficiency were randomly enrolled in two equal groups. Pearl of Vit D as 50 000 IU/week and placebo (1 tablet per week) were prescribed in patients of case and control groups respectively for 8 weeks. At the beginning and 2 months later, 24 hours urine protein was checked in all patients.

RESULTS

There is no difference between serums Vit D level in case and control group at the beginning of the study, however at the end of the study serum Vit D level was significantly higher in the case group. There is no difference in proteinuria between case and control group at the beginning and the end of the study, while a significant difference between the changes of proteinuria before and after the study was seen in two groups ( = 0.028).

CONCLUSIONS

Vit D deficiency may exacerbate protein uric and DN, hence correction of Vit D deficiency may decrease proteinuria in diabetic patients with nephropathy.

摘要

背景

维生素D(Vit D)缺乏是糖尿病患者的常见病症,可能是缺血性心脏病和糖尿病肾病(DN)加重的危险因素。

目的

本研究旨在评估Vit D3治疗对血清Vit D缺乏或不足的2型糖尿病患者蛋白尿的影响。

患者与方法

在一项双盲临床试验中,将60例蛋白尿大于150mg/天且存在Vit D缺乏或不足的2型糖尿病患者随机分为两组。病例组患者服用50000IU/周的Vit D丸剂,对照组患者服用安慰剂(每周1片),持续8周。在研究开始时和2个月后,检查所有患者的24小时尿蛋白。

结果

研究开始时,病例组和对照组的血清Vit D水平无差异,但研究结束时,病例组的血清Vit D水平显著更高。研究开始和结束时,病例组和对照组的蛋白尿无差异,但两组研究前后蛋白尿变化存在显著差异(P = 0.028)。

结论

Vit D缺乏可能会加重蛋白尿和DN,因此纠正Vit D缺乏可能会降低糖尿病肾病患者的蛋白尿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/5106877/7151acf5985c/jnp-6-10-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验